Keros Therapeutics (KROS) Receivables - Net (2021 - 2025)
Historic Receivables - Net for Keros Therapeutics (KROS) over the last 4 years, with Q3 2025 value amounting to $3.5 million.
- Keros Therapeutics' Receivables - Net rose 80000.0% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year increase of 80000.0%. This contributed to the annual value of $2.7 million for FY2024, which is 181748.25% up from last year.
- As of Q3 2025, Keros Therapeutics' Receivables - Net stood at $3.5 million, which was up 80000.0% from $15.8 million recorded in Q2 2025.
- In the past 5 years, Keros Therapeutics' Receivables - Net ranged from a high of $18.0 million in Q4 2021 and a low of $4000.0 during Q2 2024
- For the 4-year period, Keros Therapeutics' Receivables - Net averaged around $5.8 million, with its median value being $1.6 million (2024).
- Examining YoY changes over the last 5 years, Keros Therapeutics' Receivables - Net showed a top increase of 39530000.0% in 2025 and a maximum decrease of 80000.0% in 2025.
- Quarter analysis of 4 years shows Keros Therapeutics' Receivables - Net stood at $18.0 million in 2021, then crashed by 99.21% to $143000.0 in 2023, then skyrocketed by 1817.48% to $2.7 million in 2024, then rose by 27.35% to $3.5 million in 2025.
- Its Receivables - Net was $3.5 million in Q3 2025, compared to $15.8 million in Q2 2025 and $17.3 million in Q1 2025.